Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 12279
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 4.10nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 4.10nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 4.30nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 4.70nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 5.5nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 5.80nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 7.10nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 7.20nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 9nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
3D Structure (crystal)TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 9.80nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 9.80nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 10nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 10.8nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 14.8nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 15.4nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 17.5nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 20.7nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 22.6nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 23nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 27.5nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 63.8nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 155nMAssay Description:(a) The positive control SHP099 was prepared according to the reported literature (J Med Chem 2016, 59 (17), 7773-82); and the positive control TNO15...More data for this Ligand-Target Pair
